Literature DB >> 3323608

Carnitine metabolism in chronic renal failure.

G Guarnieri1, G Toigo, L Crapesi, R Situlin, M A Del Bianco, M Corsi, P LoGreco, G Paviotti, G Mioni, L Campanacci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3323608

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN： 0098-6577            Impact factor:   10.545


× No keyword cloud information.
  6 in total

Review 1.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

2.  Influence of sex and chronic haemodialysis treatment on total, free and acyl carnitine concentrations in human serum.

Authors:  A S Alhomida; S H Sobki; M H al-Sulaiman; A A al-Khader
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

3.  Amino acid and carnitine supplementation in haemodialysed children.

Authors:  J Zachwieja; M Duran; J A Joles; P J Allers; D van de Hurk; J J Frankhuisen; R A Donckerwolcke
Journal:  Pediatr Nephrol       Date:  1994-12       Impact factor: 3.714

Review 4.  Pharmacokinetics of L-carnitine.

Authors:  Allan M Evans; Gianfranco Fornasini
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Mitochondria: a new therapeutic target in chronic kidney disease.

Authors:  Simona Granata; Alessandra Dalla Gassa; Paola Tomei; Antonio Lupo; Gianluigi Zaza
Journal:  Nutr Metab (Lond)       Date:  2015-11-25       Impact factor: 4.169

6.  Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients.

Authors:  Zaher Armaly; Suheil Artol; Adel R Jabbour; Amer Saffouri; Nayef Habashi; Amir Abd Elkadir; Naser Ghattas; Raymond Farah; Safa Kinaneh; William Nseir
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.